Engineering of Multiple Modules to Improve Amorphadiene Production in Bacillus subtilis Using CRISPR-Cas9

Engineering strategies to improve terpenoids' production in Bacillus subtilis mainly focus on 2C-methyl-d-erythritol-4-phosphate (MEP) pathway overexpression. To systematically engineer the chassis strain for higher amorphadiene (precursor of artemisinin) production, a clustered regularly interspaced short palindromic repeat-Cas9 (CRISPR-Cas9) system was established in B. subtilis to facilitate precise and efficient genome editing. Then, this system was employed to engineer three more modules to improve amorphadiene production, including the terpene synthase module, the branch pathway module, and the central metabolic pathway module. Finally, our combination of all of the useful strategies within one strain significantly increased extracellular amorphadiene production from 81 to 116 mg/L after 48 h flask fermentation without medium optimization. For the first time, we attenuated the FPP-derived competing pathway to improve amorphadiene biosynthesis and investigated how the TCA cycle affects amorphadiene production in B. subtilis. Overall, this study provides a universal strategy for further increasing terpenoids' production in B. subtilis by comprehensive and systematic metabolic engineering.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:69

Enthalten in:

Journal of agricultural and food chemistry - 69(2021), 16 vom: 28. Apr., Seite 4785-4794

Sprache:

Englisch

Beteiligte Personen:

Song, Yafeng [VerfasserIn]
He, Siqi [VerfasserIn]
Abdallah, Ingy I [VerfasserIn]
Jopkiewicz, Anita [VerfasserIn]
Setroikromo, Rita [VerfasserIn]
van Merkerk, Ronald [VerfasserIn]
Tepper, Pieter G [VerfasserIn]
Quax, Wim J [VerfasserIn]

Links:

Volltext

Themen:

Amorpha-4,11-diene
Amorphadiene synthase
Bacillus subtilis
CRISPR-Cas9
Journal Article
MEP
Metabolic engineering
Polycyclic Sesquiterpenes
TCA cycle

Anmerkungen:

Date Completed 14.05.2021

Date Revised 28.05.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jafc.1c00498

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM324322666